1. Home
  2. VRTS vs MGTX Comparison

VRTS vs MGTX Comparison

Compare VRTS & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virtus Investment Partners Inc.

VRTS

Virtus Investment Partners Inc.

HOLD

Current Price

$167.45

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

HOLD

Current Price

$14.64

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRTS
MGTX
Founded
1988
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
VRTS
MGTX
Price
$167.45
$14.64
Analyst Decision
Hold
Strong Buy
Analyst Count
4
7
Target Price
$158.00
$24.57
AVG Volume (30 Days)
112.2K
505.8K
Earning Date
05-01-2026
05-12-2026
Dividend Yield
6.68%
N/A
EPS Growth
18.24
33.02
EPS
7.72
1.30
Revenue
N/A
$81,391,000.00
Revenue This Year
N/A
$141.38
Revenue Next Year
$1.66
N/A
P/E Ratio
$21.59
$11.52
Revenue Growth
N/A
144.57
52 Week Low
$121.61
$6.62
52 Week High
$203.61
$15.35

Technical Indicators

Market Signals
Indicator
VRTS
MGTX
Relative Strength Index (RSI) 55.93 69.44
Support Level $161.58 $7.04
Resistance Level $170.30 $15.35
Average True Range (ATR) 3.97 0.66
MACD -0.52 0.21
Stochastic Oscillator 58.85 90.45

Price Performance

Historical Comparison
VRTS
MGTX

About VRTS Virtus Investment Partners Inc.

Virtus Investment Partners Inc provides investment management and related services to institutions and individuals. It uses a multi-manager, multi-style approach, offering investment strategies from investment managers, each having its distinct investment style, autonomous investment process, and individual brand, as well as from select unaffiliated managers for certain funds. Through its multi-manager model, the group provides investment managers with distribution, business, and operational support. The Company operates in one business segment, namely as an asset manager providing investment management and related services for individual and institutional clients.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Share on Social Networks: